Cargando…

Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure

INTRODUCTION: The need to indentify patients with chronic heart failure (CHF) at a higher risk of major adverse cardiovascular events (MACEs) has become increasingly important; therefore, new parameters, such as health-related quality of life (HRQoL), are gaining ground. THE AIM OF THIS STUDY: The a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szyguła-Jurkiewicz, Bożena, Zakliczyński, Michał, Owczarek, Aleksander, Partyka, Robert, Mościński, Mateusz, Pudlo, Robert, Kaczmarczyk, Marcin, Zembala, Marian, Poloński, Lech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Heart and Lung Failure, Transplantology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283881/ https://www.ncbi.nlm.nih.gov/pubmed/26336436 http://dx.doi.org/10.5114/kitp.2014.45678

Ejemplares similares

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Coincidence of cellular and antibody mediated rejection in heart transplant recipients – preliminary report
por: Zakliczyński, Michał, et al.
Publicado: (2014)

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Monitoring hemostasis parameters in left ventricular assist device recipients – a preliminary report
por: Hudzik, Bartosz, et al.
Publicado: (2016)

Bridge to recovery in two cases of dilated cardiomyopathy after long-term mechanical circulatory support
por: Pacholewicz, Jerzy, et al.
Publicado: (2014)

Influence of proliferation signal inhibitors on vascular endothelial growth factor production in heart transplant recipients – preliminary report
por: Kamieńska, Natalia, et al.
Publicado: (2014)

A functional assessment of patients two years after lung transplantation in Poland
por: Jastrzębski, Dariusz T., et al.
Publicado: (2014)

Meeting Update: International Society for Heart and Lung Transplantation 2014
por: Baran, David A., et al.
Publicado: (2015)

Is cytoimmunological monitoring a safe follow-up method for heart transplantation patients?
por: Cingoz, Faruk, et al.
Publicado: (2014)

Does the postoperative troponin I blood concentration measured in the perioperative period influence hemodynamic function of a transplanted heart?
por: Wierzbicki, Karol, et al.
Publicado: (2014)

The impact of chronic kidney disease on the annual prognosis in patients 80+ years old suffering from chronic heart failure
por: Cichocka-Radwan, Anna, et al.
Publicado: (2014)

Surgery for massive malignant tumors of the left atrium – one center’s experience
por: Andrushchuk, Uladzimir, et al.
Publicado: (2016)

Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization
por: Pyka, Łukasz, et al.
Publicado: (2017)

Once– versus twice–daily tacrolimus: are the formulations equivalent?
por: Ciszek, Michał
Publicado: (2013)

Serum albumin and prognosis in elderly patients with nonischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2023)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study
por: Yousaf, Fahad, et al.
Publicado: (2012)

Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life()
por: Jakovljevic, Djordje G., et al.
Publicado: (2014)

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Obesity paradox in heart failure patients – Female gender characteristics-KAMC-single center experience
por: Khaled, Sheeren, et al.
Publicado: (2017)

Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure
por: Abdellah, Ahmad Tageldien, et al.
Publicado: (2017)

Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients
por: Mohammed, Haitham Galal, et al.
Publicado: (2018)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction
por: Abuomara, Hossamaldin Zaki Alsayed, et al.
Publicado: (2018)

Assessment of right ventricular function by echocardiography in patients with chronic heart failure
por: William, Viola, et al.
Publicado: (2018)

Prevalence of P wave dispersion and interatrial block in patients with systolic heart failure and their relationship with functional status, hospitalization and one year mortality
por: Abdellah, Ahmed Tageldien, et al.
Publicado: (2018)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Guimaraes, Leonardo, et al.
Publicado: (2020)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
por: Protonotarios, Alexandros, et al.
Publicado: (2020)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

Asymptomatic Left Ventricle Systolic Dysfunction
por: Sara, Jaskanwal D, et al.
Publicado: (2020)

Contemporary Management of Secondary Mitral Regurgitation
por: Goel, Kashish, et al.
Publicado: (2020)

Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
por: Martínez, Felipe
Publicado: (2021)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5tuk9g2i0nt4i4k2226d9gvrou